SCHEMBL4352355

SCHEMBL4352355

COc1ccc(F)cc1C(=O)c1cnc(NCCc2c[nH]c3ccccc23)nc1N

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 7/20 0.54
DRD2 P14416 6/20 0.54
HTR2A P28223 6/20 0.54
HTR7 P34969 6/20 0.54
HTR6 P50406 6/20 0.54
SLC6A4 P31645 1/20 0.51
CDK2 P24941 3/20 0.48
CDK4 P11802 2/20 0.48
CCND1 P24385 2/20 0.48
CDK1 P06493 1/20 0.48
HDAC3 O15379 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC2 Q92769 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
MAPT P10636 3/20 0.46
NPSR1 Q6W5P4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4358772 0.79 CDK1 (0.56) CDK2CDK4CCND1CDK1
SCHEMBL4352509 0.78 CDK1 (0.56) CDK2CDK4CCND1CDK1
SCHEMBL13632163 0.76 CDK1 (0.63) CDK2CDK4CCND1CDK1
SCHEMBL4354535 0.75 CDK1 (0.53) CDK2CDK4CCND1CDK1
SCHEMBL3524063 0.75 CDK1 (0.59) CDK2CDK4CCND1CDK1
SCHEMBL4352534 0.75 CDK1 (0.59) CDK2CDK4CCND1CDK1
SCHEMBL4359245 0.73 CDK1 (0.55) HTR1ADRD2CDK2CDK4CCND1
SCHEMBL4354378 0.73 CDK1 (0.51) CDK2CDK4CCND1CDK1
SCHEMBL13621453 0.71 CDK1 (0.76) CDK2CDK4CCND1CDK1
SCHEMBL4347382 0.71 CDK1 (0.76) CDK2CDK4CCND1CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7615634-B2 4-aminopyrimidine-5-one derivatives HOFFMANN-LA ROCHE INC. (US) 2009-11-10 US disclosed
US-7615634-B2 4-aminopyrimidine-5-one derivatives HOFFMANN-LA ROCHE INC. (US) 2009-11-10 US disclosed
US-7615634-B2 4-aminopyrimidine-5-one derivatives HOFFMANN-LA ROCHE INC. (US) 2009-11-10 US disclosed
US-7157455-B2 4-Aminopyrimidine-5-one derivatives HOFFMANN-LA ROCHE INC. (US) 2007-01-02 US disclosed
US-7157455-B2 4-Aminopyrimidine-5-one derivatives HOFFMANN-LA ROCHE INC. (US) 2007-01-02 US disclosed
US-20060229330-A1 4-aminopyrimidine-5-one derivatives BARTKOVITZ DAVID J 2006-10-12 US disclosed
EP-1628619-A2 4-AMINOPYRIMIDINE-5-ONE F.HOFFMANN-LA ROCHE AG (CH) 2006-03-01 EP disclosed
US-20040162303-A1 4-aminopyrimidine-5-one derivatives BARTKOVITZ DAVID JOSEPH (US) 2004-08-19 US disclosed
WO-2004069139-A2 4-AMINOPYRIMIDIN-5-YL-METHANONE DERIVATIVES FOR INHIBITION OF CDK4 ACTIVITY F.HOFFMANN-LA ROCHE AG (CH) 2004-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040162303-A1 4-aminopyrimidine-5-one derivatives CDK4, CDKL4, CDK6 HTR1A 3063/4885DRD2 2725/4885HTR2A 3772/4885
US-20060229330-A1 4-aminopyrimidine-5-one derivatives CDK4, CDKL4, CDK2 HTR1A 3073/4885DRD2 2989/4885HTR2A 3482/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.